Evidence map›Paper›PMID 32880035›Full record

ArticleJournal of community genetics2021

Reproductive decision-making in the context of hereditary cancer: the effects of an online decision aid on informed decision-making.

Kelly Reumkens, Marly H E Tummers, Yil Severijns, Joyce J G Gietel-Habets, Sander M J van Kuijk, Cora M Aalfs, Christi J van Asperen, Margreet G E M Ausems, Margriet Collée, Charlotte J Dommering and 7 more

Open access · hybridAbstract read
In one paragraph

Article in Journal of community genetics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 16 citations in OpenAlex.

  1. Genetically guided precision medicine clinical decision support tools: a systematic review.Journal of the American Medical Informatics Association : JAMIA · 2024
    Pooled it
  2. Article
  3. Article
  4. Article
  5. Impact ofCancers · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 10 institutions in 3 countries.

Kelly ReumkensDepartment of Clinical Genetics, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Marly H E TummersDepartment of Clinical Genetics, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Yil SeverijnsGROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, the Netherlands. yil.severijns@maastrichtuniversity.nl.ORCID http://orcid.org/0000-0002-8138-4741
Joyce J G Gietel-HabetsDepartment of Clinical Genetics, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Sander M J van KuijkDepartment of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Cora M AalfsDepartment of Clinical Genetics, Amsterdam UMC, Academic Medical Centre, Amsterdam, the Netherlands.
Christi J van AsperenDepartment of Clinical Genetics, Leiden University Medical Center, Leiden, the Netherlands.
Margreet G E M AusemsDepartment of Genetics, Division of Biomedical Genetics, University Medical Center Utrecht, Utrecht, the Netherlands.
Margriet ColléeDepartment of Clinical Genetics, Erasmus University Medical Center, Rotterdam, the Netherlands.
Charlotte J DommeringDepartment of Clinical Genetics, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
Marleen KetsDepartment of Human Genetics, Radboud University Medical Center Nijmegen, Nijmegen, the Netherlands.
Lizet E van der KolkFamily Cancer Clinic, Netherlands Cancer Institute, Amsterdam, the Netherlands.
Jan C OosterwijkDepartment of Genetics, Groningen University Medical Center, University of Groningen, Groningen, the Netherlands.
Vivianne C G Tjan-HeijnenGROW School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Trudy van der WeijdenDepartment of Family Medicine, School CAPHRI, Faculty of Health, Medicine and Life Sciences, Maastricht University, Maastricht, the Netherlands.
Christine E M de Die-SmuldersDepartment of Clinical Genetics, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Liesbeth A D M van OschDepartment of Clinical Genetics, Maastricht University Medical Centre+, Maastricht, the Netherlands.
Maastricht University Medical Centre · NLAmsterdam UMC Location University of Amsterdam · NLAmsterdam University Medical Centers · NLErasmus MC · NLLeiden University Medical Center · NLMaastricht University · NLRadboud University Nijmegen · NLThe Netherlands Cancer Institute · NLUniversity Medical Center Groningen · NLUniversity Medical Center Utrecht · NL

Funding

Alpe d'HuZes UM2013-6374).
6 · The paper itself

Abstract

Individuals having a genetic predisposition to cancer and their partners face challenging decisions regarding their wish to have children. This study aimed to determine the effects of an online decision aid to support couples in making an informed decision regarding their reproductive options. A nationwide pretest-posttest study was conducted in the Netherlands among 131 participants between November 2016 and May 2018. Couples were eligible for participation if one partner had a pathogenic variant predisposing for an autosomal dominant hereditary cancer syndrome. Participants completed a questionnaire before use (T0), and at 3 months (T3) after use of the decision aid to assess the primary outcome measure informed decision-making, and the secondary outcome measures decisional conflict, knowledge, realistic expectations, level of deliberation, and decision self-efficacy. T0-T3 comparisons show an overall positive effect for all outcome measures (all ps < 0.05; knowledge (ES = - 1.05), decisional conflict (ES = 0.99), participants' decision self-efficacy (ES = -0.55), level of deliberation (ES = - 0.50), and realistic expectations (ES = - 0.44). Informed decision-making increased over time and 58.0% of the participants made an informed reproductive decision at T3. The online decision aid seems to be an appropriate tool to complement standard reproductive counseling to support our target group in making an informed reproductive decision. Use of the decision aid may lessen the negative psychological impact of decision-making on couples' daily life and wellbeing.

Indexed as

Decision aidHereditary cancerPatient participationPreimplantation genetic testingPrenatal diagnosis

Identifiers

PMID32880035
PMCPMC7846643
OpenAlexW3083302654

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.